Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds

Align Technology NASDAQ: ALGN sees continued growth potential for Invisalign clear aligners in the United States and internationally despite a challenging consumer environment, Chief Financial Officer John Morici said during a Baird investor conference.

MarketBeat • Sep 18, 2026

Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript

Align Technology, Inc. (ALGN) Presents at 2026 Global Healthcare Conference Transcript

Seeking Alpha • Sep 15, 2026

Should You Continue to Hold ALGN Stock in Your Portfolio?

Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.

Zacks Investment Research • Sep 14, 2026

Align Technology to Speak at Upcoming Financial Conference

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at ht.

Business Wire • Sep 8, 2026

Quentin Blackford to Join Align Technology Board of Directors

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediat.

Business Wire • Aug 31, 2026

Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Aug 28, 2026

How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook

Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.

Zacks Investment Research • Aug 17, 2026

Should Investors Buy Align as Growth Meets Valuation and Demand Risks?

ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.

Zacks Investment Research • Aug 14, 2026

Align Technology Prevails in China Patent Infringement Action Against Angelalign

SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK). In September 2025, Align filed a.

Business Wire • Aug 12, 2026

Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple

Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows despite structural business improvements. Competitive pressures have eased post-SmileDirectClub exit, with ALGN retaining dominant market share and shifting growth toward international and DSO channels. Operating margins are expanding, management continues to raise guidance, and a robust buyback program is underway, supported by strong free cash flow.

Seeking Alpha • Aug 7, 2026